Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,762 across all filing types
Latest filing 2024-02-29 Board/Management Inform…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Change in Management
Board/Management Information Classification · 100% confidence The document is an official communication addressed to the stock exchanges (BSE and NSE) regarding a change in senior management personnel. It specifically informs about the superannuation of Ashok Modi, Executive Director (Procurement), effective 29th February 2024. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in senior management. The content includes details required under the regulation and is clearly an announcement of management change rather than a full report or financial document. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, with no financial data or other report content.
2024-02-29 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short notice (1376 characters) informing the stock exchanges (BSE and NSE) about the schedule of an investor meeting, specifically participation in the Kotak Chasing Growth Conference 2024. It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which relates to disclosure of events or information. There is no financial data, no detailed presentation, no report attached or referenced as being published, and no detailed management discussion. The document is essentially an announcement of an upcoming investor event. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2024-02-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges (BSE and NSE) about the schedule of an investor meeting (Kotak Chasing Growth Conference 2024). It is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no financial data, no detailed presentation, no report attached or referenced as being published. The document is essentially an announcement of an event related to investor relations. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation since it does not contain substantive financial or strategic content. Given the nature and length of the document, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-02-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter dated 12th February 2024 addressed to stock exchanges (BSE and NSE) regarding the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of the schedule of investor meetings, not a financial report or detailed presentation. The document length is only 1600 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and miscellaneous filings that do not fit other categories.
2024-02-12 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) informing them about the schedule of upcoming investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content is purely an announcement of scheduled investor meetings, with no financial data, report, or detailed presentation included. The document length is only 1600 characters, which is quite short and does not contain any financial statements or detailed analysis. Therefore, it is not an investor presentation (IP) or any financial report. It is a regulatory announcement about investor meetings, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2024-02-12 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about administrative action related to share certificates, not a financial report, earnings release, or management discussion. It is not a report publication announcement or a certification. The document is an official regulatory communication about share certificate issuance, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Share Issue/Capital Change (SHA) since it is about duplicate certificates, not new share issuance or capital changes.
2024-02-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.